Manel Mata-Cases, Sara Artola, Javier Escalada, Patxi Ezkurra-Loyola, Juan Carlos Ferrer-García, José Antonio Fornos, Juan Girbés, Itxaso Rica, en nombre del Grupo de Trabajo de Consensos y Guías Clínicas de la Sociedad Española de Diabetes
{"title":"对前驱糖尿病的检测和管理达成共识。西班牙糖尿病学会共识和临床指南工作组","authors":"Manel Mata-Cases, Sara Artola, Javier Escalada, Patxi Ezkurra-Loyola, Juan Carlos Ferrer-García, José Antonio Fornos, Juan Girbés, Itxaso Rica, en nombre del Grupo de Trabajo de Consensos y Guías Clínicas de la Sociedad Española de Diabetes","doi":"10.1016/j.avdiab.2014.10.007","DOIUrl":null,"url":null,"abstract":"<div><p>In Spain, according to the <span><span>[email protected]</span></span><svg><path></path></svg> study, 13.8% of the adult population suffers from diabetes and 14.8% from some form of prediabetes (impaired glucose tolerance, impaired fasting glucose or both). Since early detection of prediabetes can facilitate the implementation of therapeutic measures to prevent its progression to diabetes, we believe that preventive strategies in primary care and specialized clinical settings should be agreed. Screening for diabetes and prediabetes using a specific questionnaire (FINDRISC) and/or the measurement of fasting plasma glucose in high risk patients leads to detecting patients at risk of developing diabetes and it is necessary to consider how they should be managed. The intervention in lifestyle can reduce the progression to diabetes and reverse a prediabetic state to normal and is a cost-effective intervention. Some drugs, such as metformin, have also been shown effective in reducing the progression to diabetes but are not superior to non-pharmacological interventions. Finally, an improvement in some cardiovascular risk factors has been observed although there is no strong evidence supporting the effectiveness of screening in terms of morbility and mortality.</p><p>The Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society has issued some recommendations that have been agreed by the Sociedad Española de Endocrinología y Nutrición, Sociedad Española de Endocrinología Pediátrica, Sociedad Española de Farmacia Comunitaria, Sociedad Española de Medicina Familiar y Comunitaria, Sociedad Española de Médicos Generales, Sociedad Española de Médicos de Atención Primaria, Sociedad Española de Medicina Interna, Asociación de Enfermería Comunitaria and Red de Grupos de Estudio de la Diabetes en Atención Primaria.</p></div>","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"31 3","pages":"Pages 89-101"},"PeriodicalIF":0.0000,"publicationDate":"2015-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2014.10.007","citationCount":"0","resultStr":"{\"title\":\"Consenso sobre la detección y el manejo de la prediabetes. Grupo de Trabajo de Consensos y Guías Clínicas de la Sociedad Española de Diabetes\",\"authors\":\"Manel Mata-Cases, Sara Artola, Javier Escalada, Patxi Ezkurra-Loyola, Juan Carlos Ferrer-García, José Antonio Fornos, Juan Girbés, Itxaso Rica, en nombre del Grupo de Trabajo de Consensos y Guías Clínicas de la Sociedad Española de Diabetes\",\"doi\":\"10.1016/j.avdiab.2014.10.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>In Spain, according to the <span><span>[email protected]</span></span><svg><path></path></svg> study, 13.8% of the adult population suffers from diabetes and 14.8% from some form of prediabetes (impaired glucose tolerance, impaired fasting glucose or both). Since early detection of prediabetes can facilitate the implementation of therapeutic measures to prevent its progression to diabetes, we believe that preventive strategies in primary care and specialized clinical settings should be agreed. Screening for diabetes and prediabetes using a specific questionnaire (FINDRISC) and/or the measurement of fasting plasma glucose in high risk patients leads to detecting patients at risk of developing diabetes and it is necessary to consider how they should be managed. The intervention in lifestyle can reduce the progression to diabetes and reverse a prediabetic state to normal and is a cost-effective intervention. Some drugs, such as metformin, have also been shown effective in reducing the progression to diabetes but are not superior to non-pharmacological interventions. Finally, an improvement in some cardiovascular risk factors has been observed although there is no strong evidence supporting the effectiveness of screening in terms of morbility and mortality.</p><p>The Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society has issued some recommendations that have been agreed by the Sociedad Española de Endocrinología y Nutrición, Sociedad Española de Endocrinología Pediátrica, Sociedad Española de Farmacia Comunitaria, Sociedad Española de Medicina Familiar y Comunitaria, Sociedad Española de Médicos Generales, Sociedad Española de Médicos de Atención Primaria, Sociedad Española de Medicina Interna, Asociación de Enfermería Comunitaria and Red de Grupos de Estudio de la Diabetes en Atención Primaria.</p></div>\",\"PeriodicalId\":100152,\"journal\":{\"name\":\"Avances en Diabetología\",\"volume\":\"31 3\",\"pages\":\"Pages 89-101\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.avdiab.2014.10.007\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Avances en Diabetología\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1134323014001501\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Avances en Diabetología","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1134323014001501","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
根据[email protected]的研究,在西班牙,13.8%的成年人患有糖尿病,14.8%患有某种形式的前驱糖尿病(葡萄糖耐量受损,空腹血糖受损或两者兼而有之)。由于早期发现糖尿病前期可以促进实施治疗措施,以防止其发展为糖尿病,我们认为初级保健和专业临床设置的预防策略应该达成一致。使用特定的问卷(FINDRISC)和/或测量高风险患者的空腹血糖来筛查糖尿病和糖尿病前期,从而发现有糖尿病发展风险的患者,并有必要考虑如何对其进行管理。生活方式的干预可以减少糖尿病的进展,使糖尿病前期状态恢复正常,是一种经济有效的干预措施。一些药物,如二甲双胍,也被证明在减少糖尿病进展方面有效,但并不优于非药物干预。最后,一些心血管危险因素的改善已经被观察到,尽管没有强有力的证据支持筛查在死亡率和死亡率方面的有效性。西班牙的共识和临床指南工作组糖尿病学会发布了一些建议已经达成的皇家社会诺拉德Endocrinologia y Nutricion,皇家社会诺拉德Endocrinologia Pediatrica,皇家社会诺拉德Farmacia Comunitaria,皇家社会诺拉德药物熟悉y Comunitaria,皇家社会诺拉德发表的医学生,皇家社会大学生诺拉德德Atencion Primaria,皇家社会诺拉德药物Interna,Asociación de Enfermería communityaria和Red de groupos de Estudio de la Diabetes en Atención primary。
Consenso sobre la detección y el manejo de la prediabetes. Grupo de Trabajo de Consensos y Guías Clínicas de la Sociedad Española de Diabetes
In Spain, according to the [email protected] study, 13.8% of the adult population suffers from diabetes and 14.8% from some form of prediabetes (impaired glucose tolerance, impaired fasting glucose or both). Since early detection of prediabetes can facilitate the implementation of therapeutic measures to prevent its progression to diabetes, we believe that preventive strategies in primary care and specialized clinical settings should be agreed. Screening for diabetes and prediabetes using a specific questionnaire (FINDRISC) and/or the measurement of fasting plasma glucose in high risk patients leads to detecting patients at risk of developing diabetes and it is necessary to consider how they should be managed. The intervention in lifestyle can reduce the progression to diabetes and reverse a prediabetic state to normal and is a cost-effective intervention. Some drugs, such as metformin, have also been shown effective in reducing the progression to diabetes but are not superior to non-pharmacological interventions. Finally, an improvement in some cardiovascular risk factors has been observed although there is no strong evidence supporting the effectiveness of screening in terms of morbility and mortality.
The Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society has issued some recommendations that have been agreed by the Sociedad Española de Endocrinología y Nutrición, Sociedad Española de Endocrinología Pediátrica, Sociedad Española de Farmacia Comunitaria, Sociedad Española de Medicina Familiar y Comunitaria, Sociedad Española de Médicos Generales, Sociedad Española de Médicos de Atención Primaria, Sociedad Española de Medicina Interna, Asociación de Enfermería Comunitaria and Red de Grupos de Estudio de la Diabetes en Atención Primaria.